Check if your research matches the topics covered in Current Cancer Drug Targets?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Researcher.Life借由意得辑在过去20年中与科研人员合作的经验,进一步探求他们在发表及科研事业上有何需求。
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang (UH Drug Discovery Institute). The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters"). Less
Overview | |
Publisher | BENTHAM SCIENCE PUBL LTD |
Language | English |
Frequency | Monthly |
General Details | |
Language | English |
Frequency | Monthly |
Publication Start Year | 2000 |
Publisher URL | Visit website |
Website URL | Visit website |
Upload your Manuscript to get
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
1.9K articles received 42.5K citationssee all
Current Cancer Drug Targets has been in operation since 2000 till date.
Current Cancer Drug Targets published with a Monthly frequency.
In 2023, Current Cancer Drug Targets publsihed 80 articles.
For Current Cancer Drug Targets, eISSN is 1873-5576 and pISSN is 1568-0096.
Citescore for Current Cancer Drug Targets is 6.4.
H Index for Current Cancer Drug Targets is 99.
SNIP score for Current Cancer Drug Targets is 0.85.
SJR for Current Cancer Drug Targets is Q2.
BENTHAM SCIENCE PUBL LTD is the publisher of Current Cancer Drug Targets.